Clinical Trial Update: Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, pharmacokinetics, and microbiology of GSK3882347 in female participants with urinary tract infections has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uncomplicated Urinary Tract Infection
• Urinary Tract Infection

Drugs mentioned

• GSK3882347

Snippet

Sponsor: GlaxoSmithKline | Conditions: Uncomplicated Urinary Tract Infections, Urinary Tract Infections | Phase 1 | Status: COMPLETED | Results posted: 2026-03-13